173 related articles for article (PubMed ID: 35437272)
41. PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer.
Webb JR; Milne K; Kroeger DR; Nelson BH
Gynecol Oncol; 2016 May; 141(2):293-302. PubMed ID: 26972336
[TBL] [Abstract][Full Text] [Related]
42. Pathology of Endometrioid and Clear Cell Carcinoma of the Ovary.
Fadare O; Parkash V
Surg Pathol Clin; 2019 Jun; 12(2):529-564. PubMed ID: 31097114
[TBL] [Abstract][Full Text] [Related]
43. B7-H4 is Inversely Correlated With T-Cell Infiltration in Clear Cell but Not Serous or Endometrioid Ovarian Cancer.
Pagnotti GM; Atkinson RM; Romeiser J; Akalin A; Korman MB; Shroyer KR
Appl Immunohistochem Mol Morphol; 2019 Aug; 27(7):515-522. PubMed ID: 29189263
[TBL] [Abstract][Full Text] [Related]
44. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
Tomsová M; Melichar B; Sedláková I; Steiner I
Gynecol Oncol; 2008 Feb; 108(2):415-20. PubMed ID: 18037158
[TBL] [Abstract][Full Text] [Related]
45. Endometriosis-associated epithelial ovarian cancer is a more complicated disease than we suspected before.
Yang ST; Chang WH; Lee NR; Lai WA; Shen SH; Lee WL; Wang PH
Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1112-1115. PubMed ID: 34794748
[TBL] [Abstract][Full Text] [Related]
46. Prognostic analysis of ovarian cancer associated with endometriosis.
Kumar S; Munkarah A; Arabi H; Bandyopadhyay S; Semaan A; Hayek K; Garg G; Morris R; Ali-Fehmi R
Am J Obstet Gynecol; 2011 Jan; 204(1):63.e1-7. PubMed ID: 21074136
[TBL] [Abstract][Full Text] [Related]
47. Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis.
Paik ES; Kim TJ; Choi CH; Kim BG; Bae DS; Lee JW
J Gynecol Oncol; 2018 Mar; 29(2):e18. PubMed ID: 29400011
[TBL] [Abstract][Full Text] [Related]
48. [Lymphocyte activation markers in patients with ovarian cancer].
Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
[TBL] [Abstract][Full Text] [Related]
49. VISTA+/CD8+ status correlates with favorable prognosis in Epithelial ovarian cancer.
Jlassi A; Manai M; Morjen M; Sahraoui G; Elasmi Allal M; ELBini-Dhouib I; Naija L; Charfi L; Rejaibi R; Ben Ahmed M; Marrakchi N; Srairi-Abid N; Mezlini A; Manai M; Mrad K; Doghri R
PLoS One; 2023; 18(3):e0278849. PubMed ID: 36952478
[TBL] [Abstract][Full Text] [Related]
50. The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.
Heckl M; Schmoeckel E; Hertlein L; Rottmann M; Jeschke U; Mayr D
PLoS One; 2018; 13(2):e0192881. PubMed ID: 29451900
[TBL] [Abstract][Full Text] [Related]
51. Prevalence of endometriosis in ovarian cancer.
Yoshikawa H; Jimbo H; Okada S; Matsumoto K; Onda T; Yasugi T; Taketani Y
Gynecol Obstet Invest; 2000; 50 Suppl 1():11-7. PubMed ID: 11093056
[TBL] [Abstract][Full Text] [Related]
52. Prognostic impact of tumor-infiltrating lymphocytes in non-small cell lung carcinomas.
Mlika M; Saidi A; Mejri N; Abdennadher M; Haddouchi C; Labidi S; Khiari H; Boussen H; Hsairi M; Mezni F
Asian Cardiovasc Thorac Ann; 2022 Feb; 30(2):177-184. PubMed ID: 34558296
[TBL] [Abstract][Full Text] [Related]
53. [Clinical significance of tumor infiltrating lymphocytes in high-grade serous ovarian carcinoma].
Huang XM; Zhang Y; Xu L; Wang M; Wang W
Zhonghua Bing Li Xue Za Zhi; 2019 Aug; 48(8):610-614. PubMed ID: 31422591
[No Abstract] [Full Text] [Related]
54. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
55. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.
Martins FC; Couturier DL; Paterson A; Karnezis AN; Chow C; Nazeran TM; Odunsi A; Gentry-Maharaj A; Vrvilo A; Hein A; Talhouk A; Osorio A; Hartkopf AD; Brooks-Wilson A; DeFazio A; Fischer A; Hartmann A; Hernandez BY; McCauley BM; Karpinskyj C; de Sousa CB; Høgdall C; Tiezzi DG; Herpel E; Taran FA; Modugno F; Keeney G; Nelson G; Steed H; Song H; Luk H; Benitez J; Alsop J; Koziak JM; Lester J; Rothstein JH; de Andrade JM; Lundvall L; Paz-Ares L; Robles-Díaz L; Wilkens LR; Garcia MJ; Intermaggio MP; Alcaraz ML; Brett MA; Beckmann MW; Jimenez-Linan M; Anglesio M; Carney ME; Schneider M; Traficante N; Pejovic N; Singh N; Le N; Sinn P; Ghatage P; Erber R; Edwards R; Vierkant R; Ness RB; Leung S; Orsulic S; Brucker SY; Kaufmann SH; Fereday S; Gayther S; Winham SJ; Kommoss S; Pejovic T; Longacre TA; McGuire V; Rhenius V; Sieh W; Shvetsov YB; Whittemore AS; Staebler A; Karlan BY; Rodriguez-Antona C; Bowtell DD; Goode EL; Høgdall E; Candido Dos Reis FJ; Gronwald J; Chang-Claude J; Moysich KB; Kelemen LE; Cook LS; Goodman MT; Fasching PA; Crawford R; Deen S; Menon U; Huntsman DG; Köbel M; Ramus SJ; Pharoah PDP; Brenton JD
Br J Cancer; 2020 Sep; 123(5):793-802. PubMed ID: 32555365
[TBL] [Abstract][Full Text] [Related]
56. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
57. Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer.
Adams SF; Levine DA; Cadungog MG; Hammond R; Facciabene A; Olvera N; Rubin SC; Boyd J; Gimotty PA; Coukos G
Cancer; 2009 Jul; 115(13):2891-902. PubMed ID: 19472394
[TBL] [Abstract][Full Text] [Related]
58. Endometriosis-associated ovarian cancer: a different clinical entity.
Leone Roberti Maggiore U; Bogani G; Paolini B; Martinelli F; Chiarello G; Spanò Bascio L; Chiappa V; Ferrero S; Ditto A; Raspagliesi F
Int J Gynecol Cancer; 2024 Jun; 34(6):863-870. PubMed ID: 38531540
[TBL] [Abstract][Full Text] [Related]
59. The malignant transformation of endometriosis: Is there a left lateral predisposition of ovarian clear cell and endometrioid carcinomas?
McMullan JC; Graham MJ; Craig EF; McCluggage WG; Hunter DH; Feeney L
Eur J Surg Oncol; 2024 Jun; 50(6):108247. PubMed ID: 38522332
[TBL] [Abstract][Full Text] [Related]
60. The dichotomy in the histogenesis of endometriosis-associated ovarian cancer: clear cell-type versus endometrioid-type adenocarcinoma.
Kajihara H; Yamada Y; Shigetomi H; Higashiura Y; Kobayashi H
Int J Gynecol Pathol; 2012 Jul; 31(4):304-12. PubMed ID: 22653342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
